Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-107A-02 for acute postoperative pain after herniorrhaphy
NCT06215859Phase 3Completed
- Sponsor
- Viatris
- Start
- Dec 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of MR-107A-02 in acute postoperative pain, sponsored by Viatris. Started Dec 2023; status: completed.
02
Drugs
MR-107A-02
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT06215859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06215859.